| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.053 | 0.08 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.053 | 0.09 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.056 | 0.09 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.053 | 0.09 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.09 |